Arbutus is a biopharmaceutical firm that develops therapies for the treatment of hepatitis B virus infection.
Business Model:
Revenue: $36M
Employees: 51-200
Address: 701 Veterans Circle
City: Warminster
State: PA
Zip: 18974
Country: US
Arbutus is a biopharmaceutical firm that develops therapies for the treatment of hepatitis B virus infection.
Contact Phone:
+12674690914
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
11/26/2010
Ticker Symbol:
ABUS
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2021 | Post-IPO Equity | $15M | 6/2011 | Post-IPO Equity | $5.2M | 10/2017 | Post-IPO Equity | 1 | $116.4M |
Roivant Sciences Roivant Sciences Roivant Sciences |
1/2018 | Post-IPO Equity | $116M |
Roivant Sciences Ltd |
12/2016 | Post-IPO Equity | $15M | 10/2010 | Grant | 1 | $2.4M |
National Institutes of Health National Institutes of Health National Institutes of Health National Institutes of Health |
12/2011 | Post-IPO Debt | 1 | $3M |
Silicon Valley Bank Silicon Valley Bank Silicon Valley Bank Silicon Valley Bank |
---|
Announced Date | Name | Price |
---|---|---|
1/2015 | OnCore Biopharma | |
3/2008 | Protiva Biotherapeutics |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|